UTILIZATION OF DRUG SALES DATA FOR THE EPIDEMIOLOGY OF CHRONIC DISEASES - THE EXAMPLE OF DIABETES

被引：23

作者：

PAPOZ, L

机构：

[1] Institut National de la Santé et de la Recherche Médicale, Villejuif

[2] Institut d’Hygiène et d’Epidémiologie, Brussels

[3] Institute for Social Medicine and Epidemiology, Berlin

[4] INSERM Unité 21, Villejuif

[5] Epidemiology Unit, Ospedale San Raffaele, Milan

[6] Diabetes Clinic, St Luke’s Hospital

[7] Department of Public Health, Belfast

[8] Hospital I. Cantacuzino, Bucharest

[9] Hospital Nuestra Señora de Sonsoles, Avila

[10] Department of Clinical Pharmacology, Karolinska Institute, Huddinge

[11] Department of Diabetology, Inselspital, Bern

[12] Department of Epidemiology and Public Health, University College, London

[13] INSERM U21, Villejuif

[14] Department of Diabetes, St Bartholomew’s Hospital, London

[15] Genetic Epidemiology Unit, Odense

[16] Diabetes Center, Hippokration Hospital, Athens

[17] INSERM U21, Villejuif

[18] Associacao Protectora dos Diabeticos, Lisbon

[19] Cattedra di Clinica Medica, Ospedale San Raffaele, Milan

[20] Department of Community Medicine, Addenbrooks Hospital, Cambridge

[21] EC COMAC Epidemiology, Institut d’Hygiène et d’Epidèmiologie, Brussels

来源：

EPIDEMIOLOGY | 1993年 / 4卷 / 05期

关键词：

CHRONIC DISEASES; DIABETES-MELLITUS; DRUG CONSUMPTION; PREVALENCE; PHARMACOEPIDEMIOLOGY; INSULIN; BIGUANIDES; SULFONYLUREA COMPOUNDS;

D O I：

10.1097/00001648-199309000-00007

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

An indirect method for estimating the prevalence rates of chronic diseases that are treated by specific drugs was proposed in 1988 to European countries in the framework of a European Community concerted action on diabetes epidemiology. Data on consumption of antidiabetic drugs were collected at the national level in nine countries and at a regional level in two. Using official drug sales data and recent demographic data, we estimated the diabetes prevalence rates in each country or region. The estimated diabetes prevalence in Europe varied from 1.6% in Northern Ireland to 4.7% in Malta. In four countries that already had diabetes prevalence data, the estimation through drug consumption provided figures 3-20% lower than those from field surveys. This study showed a large variety of prescribing habits for diabetic patients in Europe (for example, the proportion of insulin-treated patients varies from 13% to 36%) and underscores the need for a consensus on antidiabetic treatments based on valid clinical research. The proposed approach does not replace field surveys but provides an inexpensive and practical marker of disease frequency and therapeutic attitudes over space and time.

引用

页码：421 / 427

页数：7

共 28 条

[1]

Studies in Drug Utilization: Methods and Applications, (1979)

[2]

Bergman U., Sjoqvist K., Measurement of drug utilization in Sweden: Methodological and clinical implications, Acta Med Scand, 683, pp. 15-22, (1984)

[3]

Stika L., Patterns in drug utilization—national and international aspects: Antidiabetic drugs, Acta Med Scand, 683, pp. 53-57, (1984)

[4]

Fontbonne A., Papoz L., Eschwege E., Drug sales data and prevalence of diabetes in France, Rev Epidemiol Santé Publique, 34, pp. 100-105, (1986)

[5]

Papoz L., Vauzelle F., Vexiau P., Cathelineau G., Pattern of treatment among diabetic patients in France, Diabetes Care, 11, pp. 586-591, (1988)

[6]

Fuller J.H., European Community Concerted Action Programme in Diabetes (EURODIAB), Diabetic Med, 6, (1989)

[7]

Walckiers D., Van der Veken J., Papoz L., Stroobant A., Prevalence of drug-treated diabetes mellitus in Belgium, Eur J Pharmacol, 43, pp. 613-619, (1992)

[8]

de Beaufort C., Michel G., Haas N., Wirion R., Glaesener G., Consommation des médicaments antidiabétiques au Grand Duché de Luxembourg, Bull Soc Sci Med Grand-Duché Luxemb, 2, pp. 5-9, (1991)

[9]

Melchert H.U., Hoffmeister H., Validation of questionnaire data on consumption of pharmaceuticals in a pharmacoepidemiological study by determination of serum levels of selected active substances, J Clin Res Drug Dev, 2, pp. 184-185, (1988)

[10]

Teuscher T., Teuscher A.U., Teuscher A., Diabetes-Häufigkeit in der Schweiz, Dritter Schweizerischer Emährungsbericht, pp. 413-422, (1991)

← 1 2 3 →